• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»All facts about SARS-CoV2 and COVID-19 disease

All facts about SARS-CoV2 and COVID-19 disease

0
By Biotech Express on April 21, 2020 Articles, SARS- CoV2 & COVID-19 Updates

by  Kamal Pratap Singh, Managing Editor, Biotech Express

E-mail- kamal9871@gmail.com

 

Coronaviruses (CoVs): Introduction

Coronaviruses (CoV) are member of a group of related viruses that cause diseases in mammals and birds. There are many diverse groups of viruses and each group contains further more different viruses (see complete phylogeny here). Novel CoV-2019’s story is not very old, a new group of viruses with the name of coronaviruses have been recognized by an informal group of virologists who have sent their conclusions to Nature and consequently in 1975 the International Committee on the Taxonomy of Viruses (ICTV) approved the creation of a new family, Coronaviridae, with one genus, Coronavirus (Tyrrell et al., 1975).

Find out more relevant info about Coronaviruses: https://www.who.int/health-topics/coronavirus#tab=tab_1

 

CoVs: Classification

Coronaviruses (CoVs) are the largest group of viruses belonging to the Nidovirales order, which includes 4 families Coronaviridae, Arteriviridae, Mesoniviridae, and Roniviridae. The  Coronavirinae Suborder is further subdivided into Coronaviridae family, two subfamilies Letovirinae and Orthocoronavirinae four genera the alpha, beta, gamma, and delta coronaviruses and further into 24 subgenera and 39 species (more on ICTV). One of the oldest review on coronaviruses which explained about them in detail was published in 1983.

With introduction of SARS-CoV2, coronaviruses which affects Human are now of 7 types:

  1. 229E (alpha coronavirus)
  2. NL63 (alpha coronavirus)
  3. OC43 (beta coronavirus)
  4. HKU1 (beta coronavirus)
  5. MERS-CoV (the beta coronavirus that causes Middle East Respiratory Syndrome, or MERS)
  6. SARS-CoV (the beta coronavirus that causes severe acute respiratory syndrome, or SARS)
  7. SARS-CoV-2 (the novel coronavirus that is causing coronavirus disease 2019 or COVID19, it is attached to beta coronavirus species as we will see in next headings )

Image: Phylogenetic analysis of RNA-dependent RNA polymerases (Pol) of coronaviruses with complete genome sequences available. (Image source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185738/)

People around the world commonly get infected with human coronaviruses 229E, NL63, OC43, and HKU1. Sometimes coronaviruses that infect animals can evolve and make people sick and become a new human coronavirus. Three recent examples of this are SARS2 CoV2019, SARS-CoV, and MERS-CoV (https://www.cdc.gov/coronavirus/types.html).

Find out more relevant info: https://www.sciencedirect.com/topics/neuroscience/coronavirus

 

Recognizing Coronavirus: Identification and naming of novel CoV

CoVs have a crown-like appearance due to the presence of spike glycoproteins on the envelope under an electron microscope (coronam is the Latin term for crown). The Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses assessed the placement of the human pathogen which was tentatively named 2019-nCoV (Reference), within the Coronaviridae. The CSG recognizes this virus as forming a sister clade to the human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) and designates it as SARS-CoV-2. They further proposed to use the following naming convention for individual isolates: SARS-CoV-2/host/location/isolate/date.

Find out more relevant info: https://www.nature.com/articles/s41564-020-0695-z

 

CoVs Structure: What they look like?

All viruses in the Nidovirales order are enveloped, coronavirus virions are spherical in shape. The coronaviral genome encodes four major structural proteins: the spike (S) protein, nucleocapsid (N) protein, membrane (M) protein, and the envelope (E) protein and many non-structural proteins. Little information is available toward the complete proteome of SARS-CoV2, the main proteins that are usaual in CoVs or have been studied in SARS-CoV-2 are:

Coronavirus-structure

The S protein is ~150 kDa. It utilizes peptide terminal signal sequence to gain access to the Endoplasmic Reticulum and is heavily N-linked glycosylated. Homotrimers of the virus encoded S protein make up the distinctive spike structure on the surface of the virus. The trimeric S glycoprotein is a class I fusion protein and mediates attachment to the host receptor.

The N protein constitutes the only protein present in the nucleocapsid. It is composed of two separate domains, an N-terminal domain (NTD) and a C-terminal domain (CTD), both capable of binding RNA in vitro, but each domain uses different mechanisms to bind RNA. It has been suggested that optimal RNA binding requires contributions from both domains (Reference). N protein is also heavily phosphorylated and phosphorylation has been suggested to trigger a structural change enhancing the affinity for viral versus non-viral RNA.

The M protein is the most abundant structural protein in the virion. It is a small (~25–30 kDa) protein with three transmembrane domains and is thought to give the virion its shape. It has a small N-terminal glycosylated ectodomain and a much larger C-terminal endodomain that extends 6–8 nm into the viral particle. Despite being co-translationally inserted in the ER membrane, most M proteins do not contain a signal sequence.

The E protein (~8–12 kDa) is found in small quantities within the virion. The E protein has an N-terminal ectodomain and a C-terminal endodomain and has ion channel activity. The E protein facilitates assembly and release of the virus, but also has other functions. For instance, the ion channel activity in SARS-CoV E protein is not required for viral replication but is required for pathogenesis.

A fifth structural protein, the hemagglutinin-esterase (HE), is present in subset of β-coronaviruses. The protein acts as a hemagglutinin, binds sialic acids on surface glycoproteins, and contains acetyl-esterase activity. These activities are thought to enhance S protein-mediated cell entry and virus spread through the mucosa (Reference).

Find out more relevant info: https://www.uniprot.org/proteomes/UP000000354

 

Genome: What does it contain for inheritance?

The Genome of SARS – CoV2 is 30kb long single stranded positive sense RNA which is non-segmented. Positive sense RNA gives mRNA which would incorporate in host polymerase and make protein as quickly as possible. Professor Leo Poon from Hong Kong University was one of the first scientists to decode the genome of novel coronavirus.

The main aim of a virus is to enter the host cell, to acquire its genetic machinery and to make progenies which if grows in a suitable atmosphere may reach to billions or even trillions within a fraction of time and thus it carries minimum genes to carry forward their lifecycle.

Analysis of complete SARS – CoV2 genome submitted by Indian Scientists revealed that it has total 29854 bp in a linear RNA. It has several open reading frames (ORFs) and genes which are in following order orf1ab -­- Gene S — orf3a – Gene E — Gene M — orf6 — orf7a — orf8 — GeneN — orf10. Orf1ab is the longest gene in SARS COV2 which spread upto 21.5 kbp.

According to a recent study (Reference) SARS – CoV2 was found closely related (with 88% identity) to two bat-derived SARS-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that SARS- CoV2 fell within the subgenus Sarbecovirus of the genus Betacoronavirus.

Find out more relevant info: https://www.ncbi.nlm.nih.gov/protein/?term=Severe+acute+respiratory+syndrome+coronavirus+2%5Borganism%5D+AND+protein_structure_direct%5BFilt%5D

 

CoV: Transmission

SARS- CoV2 transmits from person to person although according to some theories it came from bat or pangolin which was eaten by a human in Wuhan, China. Between people it can transfer through close contact, aerosol respiratory droplets (coughing or sneezing) and by touch either through body surface of infected surfaces which have virus particles. These circulating virus particles enter the body through the mouth, eyes or nose.

The initial attachment is initiated by interactions between the S protein (S1 region) and its receptor. ACE2 receptor has been proposed as entry receptor for SARS2.

Find out more relevant info: https://www.healthline.com/health/coronavirus-transmission

 

CoV: How it harms its Host?

The incubation period for COVID-19 in human (i.e. the time between exposure to the virus and onset of symptoms) is currently estimated to between one and 14 days. The early symptoms are usually cough, fever and shortness of breath, and look a lot like the flu or common cold. Other like general weakness, fatigue and muscular pain and in the most severe cases, severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock, all potentially leads to death. Reports show that clinical deterioration can occur rapidly, often during the second week of disease. Recently, anosmia – loss of the sense of smell – (and in some cases the loss of the sense of taste) have been reported as a symptom of a COVID-19 infection.

Find out more relevant info: https://www.ecdc.europa.eu/en/covid-19/questions-answers

 

CoVs: How they multiplies?

Following receptor binding, the virus must next gain access to the host cell cytosol. This is generally accomplished by acid dependent proteolytic cleavage of S protein by a cathepsin, TMPRRS2 or another protease, followed by fusion of the viral and cellular membranes. The next step in the coronavirus lifecycle is the translation of the replicase gene from the virion genomic RNA. The replicase gene encodes two large ORFs, rep1a and rep1b, which express two co-terminal polyproteins, pp1a and pp1ab. Polyproteins pp1a and pp1ab contain the non-structural proteins (nsps) 1–11 and 1–16, respectively. These polyproteins are subsequently cleaved into the individual nsps. Coronaviruses encode either two or three proteases that cleave the replicase polyproteins. Many of the nsps assemble into the replicase–transcriptase complex (RTC) to create an environment suitable for RNA synthesis, and ultimately are responsible for RNA replication and transcription of the sub-genomic RNAs.

The nsps also contain other enzyme domains and functions, including those important for RNA replication, for example nsp12 encodes the RNAdependent RNA polymerase (RdRp) domain; nsp13 encodes the RNA helicase domain and RNA 5′-triphosphatase activity; nsp14 encodes the exoribonuclease (ExoN) involved in replication fi delity and N7-methyltransferase activity; and nsp16 encodes 2′-O-methyltransferase activity. In addition to the replication functions other activities, such as blocking innate immune responses (nsp1; nsp16-2′-O-methyl transferase; nsp3-deubiquitinase) have been identified for some of the nsps, while others have largely unknown functions.

Viral RNA synthesis produces both genomic and sub-genomic RNAs. Sub-genomic RNAs serve as mRNAs for the structural and accessory genes. Following replication and sub-genomic RNA synthesis, the viral structural proteins, S, E, and M are translated and inserted into the endoplasmic reticulum (ER). These proteins move along the secretory pathway into the endoplasmic reticulum–Golgi intermediate compartment (ERGIC). There, viral genomes encapsidated by N protein bud into membranes of the ERGIC containing viral structural proteins, forming mature virions. Following assembly, virions are transported to the cell surface in vesicles and released by exocytosis (Reference).

https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full.pdf

 

Coronavirus Tests:

When start feeling ill with COVID-19 symptoms (such as fever, cough, difficulty breathing, muscle pain or general weakness), it is recommended that you contact your local healthcare services online or by telephone ( Govt. of India helpline no. is 1075 ). ECDC has suggested prioritize testing in the following groups:

  • hospitalised patients with severe respiratory infections;
  • symptomatic healthcare staff including those with mild symptoms;
  • cases with acute respiratory infections in hospital or long-term care facilities;
  • patients with acute respiratory infections or influenza-like illness in certain outpatient clinics or hospitals;
  • elderly people with underlying chronic medical conditions such as lung disease, cancer, heart failure, cerebrovascular disease, renal disease, liver disease, diabetes, and immunocompromising conditions.

The test which performed to detect Virus is Real time Polymerase Chain Reaction (RT-PCR), a molecular test that analyze RNA of virus. Many companies are providing diagnostic kits to test COVID19 and the protocol can be found here. In India, ICMR – National Institute of Virology, Pune has been recognized as WHO reference laboratories providing confirmatory testing for COVID-19.

 

Prevention is always better than cure: How to prevent COVID19?

The virus enters our body via eyes, nose and/or mouth, so it is important to avoid touching your face with unwashed hands. Washing of hands with soap and water for at least 20 seconds, or cleaning hands thoroughly with alcohol-based solutions, gels or tissues is recommended in all settings. It is also recommended to stay 1 metre or more away from people infected with COVID-19 who are showing symptoms, to reduce the risk of infection through respiratory droplets.

 

 Vaccine is for Viruses?

As this is a new virus, no vaccine is currently available. Although work on a vaccine has already started by several research groups and pharmaceutical companies worldwide, it may be months to more than a year before a vaccine has been tested and is ready for use in humans.

Healthcare providers are mostly using a symptomatic approach, meaning they treat the symptoms rather than target the virus, and provide supportive care (e.g. oxygen therapy, fluid management) for infected persons, which can be highly effective.

 

Origin of Human CoV Pandemic

In 2003 a SARS study group at Queen Mary Hospital, University of Hong Kong analysed case notes and microbiological findings for 50 patients with severe acute respiratory syndrome. They interpreted that a coronavirus which was isolated from patients with SARS might be the primary agent associated with this disease. https://www.ncbi.nlm.nih.gov/pubmed/12711465

SCoV-like viruses were isolated from Himalayan palm civets found in a live-animal market in Guangdong, China. Evidence of virus infection was also detected in other animals (including a raccoon dog, Nyctereutes procyonoides) and in humans working at the same market. All the animal isolates retain a 29-nucleotide sequence that is not found in most human isolates. https://www.ncbi.nlm.nih.gov/pubmed/12958366

 

Origin of novel Human CoV Pandemic

There have been many skeptical theories floating around. According to one, as written by vox (https://www.vox.com/2020/3/4/21156607/how-did-the-coronavirus-get-started-china-wuhan-lab) the virus was engineered in the lab by humans as a bioweapon or the virus being studied in the lab “escaped” or “leaked” because of poor safety protocol.

According to Chinese scientists and officials, the source of the SARS2 coronavirus is believed to be a “wet market” in Wuhan which sold both dead and live animals including fish and birds. They (including Lit Man Leo Poon himself) have issues a statement in The Lancet as “We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin, Conspiracy theories do nothing but create fear, rumours, and prejudice that jeopardise our global collaboration in the fight against this virus”.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30418-9/fulltext

 

Source of the Current CoV Outbreak

Officials from the Chinese Center for Disease Control and Prevention said they have successfully isolated the virus in samples taken from a seafood and wildlife market in Wuhan believed to be the source of the outbreak. Nearly three dozen of the samples taken from the market contained the nucleic acid of the coronavirus, and 31 of those samples were collected from the section of the market dedicated to the sale of wild animals, the Chinese CDC said.

The coronavirus that caused the 2003 SARS outbreak was traced to the civet cat, a wild animal considered a delicacy in parts of South China. (https://edition.cnn.com/2020/01/27/world/coronavirus-china-bans-wildlife-trade-trnd/index.html)

 

Author Note: COVID is caused by novel virus which still needs more research therefore this article suggests readers to explore given resources. Any Suggestions/corrections are welcome.

The article has been highly plagiarised and due references are given.

 

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE

Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.